Sorrento Therapeutics has acquired 9 companies, including 4 in the last 5 years. It has also divested 1 asset.
Sorrento Therapeutics has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
4955 Directors Place,
San Diego, California
92121
United States,
(858) 203-4100
www.sorrentotherapeutics.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-02-17 |
Fortune · Life Science
Zhengzhou, China · www.fortunetest.com Fortune specializes in the manufacture of lateral flow diagnostic tests with numerous approved products marketed in over 20 countries for pregnancy tests, fecal occult blood tests, and drug abuse test kits. Fortune has an ISO 13885 facility and is capable of producing tens of millions of lateral flow tests per month. Fortune was founded in 2003 and is based in Zhengzhou, China. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
